Treatment outcomes of integrase inhibitors, boosted protease inhibitors and nonnucleoside reverse transcriptase inhibitors in antiretroviral‐naïve persons starting treatment

Author:

Mocroft A1ORCID,Neesgard B2,Zangerle R3,Rieger A4,Castagna A5,Spagnuolo V5,Antinori A6,Lampe FC1,Youle M7,Vehreschild JJ8,Mussini C9,Borghi V9,Begovac J10,Duvivier C11,Gunthard HF1213,Rauch A14,Tiraboschi J15,Chkhartishvili N15,Bolokadze N16,Wit F17,Wasmuth JC18,De Wit S19,Necsoi C19,Pradier C20,Svedhem V21,Stephan C22,Petoumenos K23,Garges H24,Rogatto F25,Peters L2,Ryom L2,

Affiliation:

1. Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London London UK

2. Department of Infectious Diseases, Section 2100, Rigshospitalet, University of Copenhagen Copenhagen Denmark

3. Medical University of Innsbruck Innsbruch Austria

4. Medical University of Vienna Vienna Austria

5. Vita‐Salute San Raffaele University Milano Italy

6. Lazzaro Spallanzani National Institute for Infectious Diseases Rome Italy

7. Royal Free Hospital London UK

8. University Hospital Cologne Cologne Germany

9. University of Modena Modena Italy

10. University Hospital of Infectious Diseases Zagreb Croatia

11. Necker University Hospital, Department of Infectious and Tropical Diseases Paris France

12. University of Zurich Zurich Switzerland

13. University Hospital of Zurich Zurich Switzerland

14. University Hospital Berne Bern Switzerland

15. PISCIS Cohort Study, Bellvitge Hospital Barcelona Spain

16. Georgian National AIDS Health Information System (AIDS HIS), Infectious Diseases, AIDS and Clinical Immunology Research Center Tbilisi Georgia

17. Stichting HIV Monitoring (SHM) Amsterdam the Netherlands

18. University Hospital Bonn Bonn Germany

19. Infectious Disease Research Centre Brussels Belgium

20. Côte d'Azur University and University Hospital Center Nice France

21. Karolinska University Hospital Stockholm Sweden

22. Johann Wolfgang Goethe‐University Hospital Frankfurt Germany

23. Kirby Institute New South Wales Australia

24. ViiV Healthcare London UK

25. Gilead Sciences Foster City, CA USA

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3